Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Radheshyam N
KDR Gene as a Predictive Biomarker of Response to Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC)
Journal of Pharmacogenomics & Pharmacoproteomics
Related publications
The Cost–Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies in Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Response to Regorafenib at an Initial Dose of 120 Mg as Salvage Therapy for Metastatic Colorectal Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Regorafenib Adjusted Dose for Chilean Patients With Chemoresistant Metastatic Colorectal Cancer: A Case Series
ecancermedicalscience
Cancer Research
Oncology
Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib
Oncologist
Cancer Research
Medicine
Oncology
Regorafenib in Combination With Silybin as a Novel Potential Strategy for the Treatment of Metastatic Colorectal Cancer
Oncotarget
Oncology
Angiogenesis Genotyping and Clinical Outcome During Regorafenib Treatment in Metastatic Colorectal Cancer Patients
Scientific Reports
Multidisciplinary
Pcn390 - Metastatic Colorectal Cancer (Mcrc) - Literature Review on Quality of Life Instruments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients With Metastatic Colorectal Cancer in a Real‐World Clinical Setting
Oncologist
Cancer Research
Medicine
Oncology
